Literature DB >> 29109603

Drug dosing in obese adults.

Michael Barras1, Amy Legg2.   

Abstract

Entities:  

Keywords:  antibiotics; anticoagulants; drug dosing education; obesity; pharmacokinetics

Year:  2017        PMID： 29109603      PMCID： PMC5662437          DOI： 10.18773/austprescr.2017.053

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  17 in total

1.  The origin of the "ideal" body weight equations.

Authors:  M P Pai; F P Paloucek
Journal:  Ann Pharmacother       Date:  2000-09       Impact factor: 3.154

Review 2.  Dose adjustment of anaesthetics in the morbidly obese.

Authors:  J Ingrande; H J M Lemmens
Journal:  Br J Anaesth       Date:  2010-12       Impact factor: 9.166

Review 3.  Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

Authors:  Jennifer J Griggs; Pamela B Mangu; Holly Anderson; Edward P Balaban; James J Dignam; William M Hryniuk; Vicki A Morrison; T May Pini; Carolyn D Runowicz; Gary L Rosner; Michelle Shayne; Alex Sparreboom; Lara E Sucheston; Gary H Lyman
Journal:  J Clin Oncol       Date:  2012-04-02       Impact factor: 44.544

Review 4.  Where to find information about drugs.

Authors:  Richard O Day; Leone Snowden
Journal:  Aust Prescr       Date:  2016-06-01

5.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

6.  Quantification of lean bodyweight.

Authors:  Sarayut Janmahasatian; Stephen B Duffull; Susan Ash; Leigh C Ward; Nuala M Byrne; Bruce Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 7.  What is the best size descriptor to use for pharmacokinetic studies in the obese?

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

8.  Development of a dosing strategy for enoxaparin in obese patients.

Authors:  Bruce Green; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

9.  Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients.

Authors:  L A Bauer; W A Edwards; E P Dellinger; D A Simonowitz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  Effect of obesity on the pharmacokinetics of drugs in humans.

Authors:  Michael J Hanley; Darrell R Abernethy; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447
View more
  14 in total

1.  Incidence of trastuzumab-induced cardiotoxicity and impact of body mass index in patients with breast cancer: Results from a Saudi tertiary cancer center.

Authors:  Khalid Al-Saleh; Ahmed Abdel-Warith; Mohammed Alghamdi; Abdurrahman Aldiab; Arwa Ali; Eyad Fawzi Alsaeed; Waleed Nabeel Abozeed; Nashwa Abdel-Aziz
Journal:  Mol Clin Oncol       Date:  2022-02-08

Review 2.  Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender.

Authors:  Massimo Iacoviello; Rosanna Pugliese; Michele Correale; Natale Daniele Brunetti
Journal:  Curr Heart Fail Rep       Date:  2022-10-05

Review 3.  Optimizing antimicrobial use: challenges, advances and opportunities.

Authors:  Timothy M Rawson; Richard C Wilson; Danny O'Hare; Pau Herrero; Andrew Kambugu; Mohammed Lamorde; Matthew Ellington; Pantelis Georgiou; Anthony Cass; William W Hope; Alison H Holmes
Journal:  Nat Rev Microbiol       Date:  2021-06-22       Impact factor: 60.633

4.  Evaluation of Total Body Weight versus Adjusted Body Weight Voriconazole Dosing in Obese Patients.

Authors:  Elizabeth Diller; Tamara Krekel; Andrej Spec; Jeff Klaus
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

5.  Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis.

Authors:  Anil R Maharaj; Huali Wu; Kanecia O Zimmerman; David G Speicher; Janice E Sullivan; Kevin Watt; Amira Al-Uzri; Elizabeth H Payne; Jinson Erinjeri; Susan Lin; Barrie Harper; Chiara Melloni; Christoph P Hornik
Journal:  J Clin Pharmacol       Date:  2019-12-08       Impact factor: 2.860

6.  Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials.

Authors:  Tomefa E Asempa; Sergey Izmailyan; Kenneth Lawrence; David P Nicolau
Journal:  Open Forum Infect Dis       Date:  2020-11-13       Impact factor: 3.835

7.  Elevated body fat increases amphetamine accumulation in brain: evidence from genetic and diet-induced forms of adiposity.

Authors:  Xiuping Fu; Aparna P Shah; Jacqueline Keighron; Ta-Chung M Mou; Bruce Ladenheim; Jesse Alt; Daisuke Fukudome; Minae Niwa; Kellie L Tamashiro; Gianluigi Tanda; Akira Sawa; Jean-Lud Cadet; Rana Rais; Jay M Baraban
Journal:  Transl Psychiatry       Date:  2021-08-14       Impact factor: 6.222

8.  Impact of High Body Weight on Mortality in Critically Ill Patients Receiving Meropenem for Pneumonia.

Authors:  Xiaofang Gao; Liling Liang; Peng Yan
Journal:  Cureus       Date:  2019-12-17

9.  Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity.

Authors:  Jose Rodríguez-Morató; Albert Goday; Klaus Langohr; Mitona Pujadas; Ester Civit; Clara Pérez-Mañá; Esther Papaseit; Jose Manuel Ramon; David Benaiges; Olga Castañer; Magí Farré; Rafael de la Torre
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

10.  Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.

Authors:  Jing Zhu; Olivia Campagne; Chad D Torrice; Gabrielle Flynn; Jordan A Miller; Tejendra Patel; Oscar Suzuki; Jonathan R Ptachcinski; Paul M Armistead; Tim Wiltshire; Donald E Mager; Daniel L Weiner; Daniel J Crona
Journal:  Clin Transl Sci       Date:  2021-01-27       Impact factor: 4.689
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.